Sia N. Hersini, Dmd, Pc | |
404 William St Suite D Geneva NY 14456-2143 | |
(315) 789-9054 | |
(315) 781-1297 |
Full Name | Sia N. Hersini, Dmd, Pc |
---|---|
Speciality | Dentist - General Practice |
Location | 404 William St, Geneva, New York |
Authorized Official Name and Position | Sia N Hersini (CEO) |
Authorized Official Contact | 3157899054 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Sia N. Hersini, Dmd, Pc 404 William St Suite D Geneva NY 14456-2143 Ph: (315) 789-9054 | Sia N. Hersini, Dmd, Pc 404 William St Suite D Geneva NY 14456-2143 Ph: (315) 789-9054 |
NPI Number | 1699807362 |
---|---|
Provider Enumeration Date | 03/09/2007 |
Last Update Date | 08/22/2020 |
Identifier | Type | State | Issuer |
---|---|---|---|
1699807362 | NPI | - | NPPES |
02146138 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | (* (Not Available)) | Primary |
News Archive
A Wayne State University School of Medicine study has found that an overwhelming majority of African-American patients with hypertension also suffered hidden heart disease caused by high blood pressure even though they displayed no symptoms.
People with Alzheimer's disease will be denied essential drug treatments as part of a new cost-cutting exercise being considered by East Sussex County Healthcare Trust.
In a paper recently uploaded to the preprint server bioRxiv by Tauzin et al. (March 18th, 2021) the ability of a single dose of mRNA vaccine to induce humoral and T cell responses against mutated variants are demonstrated and found to be reinforced in individuals with a history of COVID-19.
Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the FDA Office of Orphan Products Development has granted orphan drug designation for UX003 for the treatment of MPS 7.
› Verified 4 days ago
Frank & Dianne Triana, Dds, P.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 174 Washington St, Geneva, NY 14456 Phone: 315-789-2040 | |
Finger Lakes Migrant Health Care Project Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 601 B West Washington St, Geneva, NY 14456 Phone: 315-531-9102 Fax: 315-531-9103 | |
Eaves Family Dental Group Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 64 Elizabeth Blackwell St, Suite B, Geneva, NY 14456 Phone: 315-789-8899 | |
Lake Country Dental P.l.l.c Dental Clinic Medicare: Medicare Enrolled Practice Location: 404 William St Ste 5, Geneva, NY 14456 Phone: 315-789-3067 Fax: 315-789-0056 | |
Prindle Family Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 774 Pre Emption Rd, Geneva, NY 14456 Phone: 315-789-8975 | |
Loch Dental Care Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 789 Canandaigua Rd, Geneva, NY 14456 Phone: 315-781-9040 |